C.E.Management Integrated Laboratory Co.Ltd (TYO:6171)
Japan · Delayed Price · Currency is JPY 372.00
-1.00 (-0.27%)
Aug 27, 2026, 3:30 PM JST
TYO:6171 Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,970 | 7,695 | 7,346 | 7,326 | 6,998 | 7,341 | |
Revenue Growth | 8.08% | 4.75% | 0.27% | 4.69% | -4.67% | 18.27% |
Cost of Revenue | 4,810 | 4,697 | 4,480 | 4,590 | 4,346 | 4,806 |
Gross Profit | 3,160 | 2,998 | 2,866 | 2,736 | 2,652 | 2,535 |
Selling, General & Admin | 2,269 | 2,166 | 2,125 | 2,053 | 1,942 | 1,897 |
Amortization of Goodwill & Intangibles | 65 | 65 | 70 | 95 | 90 | 78 |
Operating Expenses | 2,425 | 2,328 | 2,284 | 2,262 | 2,118 | 2,049 |
Operating Income | 735 | 670 | 582 | 474 | 534 | 486 |
Interest Expense | -7 | -6 | -4 | -4 | -3 | -4 |
Interest & Investment Income | 17 | 15 | 25 | 11 | 11 | 23 |
Currency Exchange Gain (Loss) | - | - | - | - | -1 | - |
Other Non Operating Income (Expenses) | 25 | 26 | 3 | 6 | 22 | 85 |
EBT Excluding Unusual Items | 770 | 705 | 606 | 487 | 563 | 590 |
Gain (Loss) on Sale of Investments | 42 | 42 | - | - | -8 | -23 |
Asset Writedown | -76 | -18 | - | -113 | - | -122 |
Other Unusual Items | - | - | - | - | - | -1 |
Pretax Income | 736 | 729 | 606 | 374 | 555 | 444 |
Income Tax Expense | 243 | 247 | 244 | 184 | 206 | 231 |
Net Income | 493 | 482 | 362 | 190 | 349 | 213 |
Net Income to Common | 493 | 482 | 362 | 190 | 349 | 213 |
Net Income Growth | 38.48% | 33.15% | 90.53% | -45.56% | 63.85% | -27.30% |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | 14 |
Shares Change | 0.01% | 0.03% | 0.01% | -0.03% | -0.88% | -1.30% |
EPS (Basic) | 34.67 | 33.89 | 25.47 | 13.37 | 24.56 | 14.86 |
EPS (Diluted) | 34.67 | 33.89 | 25.47 | 13.37 | 24.56 | 14.86 |
EPS Growth | 38.49% | 33.05% | 90.53% | -45.56% | 65.30% | -26.30% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 758 | 258 | 460 | 900 | 286 | 251 |
Free Cash Flow Per Share | 53.30 | 18.14 | 32.36 | 63.31 | 20.11 | 17.50 |
Dividend Per Share | 6.000 | 12.000 | 12.000 | 12.000 | 11.000 | 9.500 |
Dividend Growth | -50.00% | 0% | 0% | 9.09% | 15.79% | 5.56% |
Gross Margin | 39.65% | 38.96% | 39.01% | 37.35% | 37.90% | 34.53% |
Operating Margin | 9.22% | 8.71% | 7.92% | 6.47% | 7.63% | 6.62% |
Profit Margin | 6.19% | 6.26% | 4.93% | 2.59% | 4.99% | 2.90% |
Free Cash Flow Margin | 9.51% | 3.35% | 6.26% | 12.29% | 4.09% | 3.42% |
EBITDA | 1,008 | 973 | 888 | 833 | 895 | 838 |
EBITDA Margin | 12.65% | 12.65% | 12.09% | 11.37% | 12.79% | 11.42% |
D&A For EBITDA | 273 | 303 | 306 | 359 | 361 | 352 |
EBIT | 735 | 670 | 582 | 474 | 534 | 486 |
EBIT Margin | 9.22% | 8.71% | 7.92% | 6.47% | 7.63% | 6.62% |
Effective Tax Rate | 33.02% | 33.88% | 40.26% | 49.20% | 37.12% | 52.03% |